+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "T Cell Therapies"

From
From
From
From
From
From
From
From
From
Global Oncology Pharmaceuticals Market 2021-2026 - Product Thumbnail Image

Global Oncology Pharmaceuticals Market 2021-2026

  • Report
  • September 2021
  • 143 Pages
  • Global
From
Cell & Gene Therapy Market - Global Outlook & Forecast 2022-2027 - Product Thumbnail Image

Cell & Gene Therapy Market - Global Outlook & Forecast 2022-2027

  • Report
  • January 2022
  • 292 Pages
  • Global
From
From
From
U.S. Gene Editing Market - Industry Outlook & Forecast 2022-2027 - Product Thumbnail Image

U.S. Gene Editing Market - Industry Outlook & Forecast 2022-2027

  • Report
  • November 2022
  • 197 Pages
  • United States
From
Loading Indicator

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more